Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma

Clinical Oncology

Volumn 5, Issue 4, 1993, Pages 198-202

  Lim, J T W ^a   Green, J A ^a  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Ifosfamide; Ovarian cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; IFOSFAMIDE; MESNA;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOTHERAPY; DRUG MIXTURE; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; LAPAROTOMY; MAJOR CLINICAL STUDY; OTOTOXICITY; OVARY CARCINOMA; PERIPHERAL NEUROPATHY; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMAN; IFOSFAMIDE; MIDDLE AGE; OVARIAN NEOPLASMS; SURVIVAL RATE;

EID: 0027327397     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(05)80227-4     Document Type: Article

References (24)

1. Cancer of the ovary: Survival studies based upon operative therapy, chemotherapy and radiotherapy
2. Surgical resection of tumour bulk in the primary treatment of ovarian carcinoma
3. Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytore-ductive surgery an independent determinant of prognosis?
4. Ovarian cancer treatment: Progress or paralysis?
5. A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (reassessed with the log (relative risk) as outcome objectives
6. Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: A Gynecologic Oncology Group Study
7. High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO Stages III and IV): Report from the North Thames Cooperative Group
8. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
9. Treatment of advanced ovarian cancer: 10 years of experience
10. Carboplatin in the treatment of ovarian cancer
11. Ifosfamide: Pharmacology, safety and therapeutic potential
12. WHO Handbook for reporting results of cancer treatment
13. Speed of response to platinum based chemotherapy: Implications for the management of epithelial ovarian carcinoma
14. The role of induction chemotherapy in inoperable ovarian cancer
15. Randomised trial comparing chemotherapy regimes (CHAP-5 vs CP) in advanced ovarian cancer
16. Primary cytoreductive surgery for epithelial ovarian cancer
17. Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer
18. Dose intensity analysis of chemotherapy regimes in ovarian carcinoma
19. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
20. A dose escalation study of carboplatin and' ifosfamide in advanced ovarian cancer
21. Ifosfamide encephalopathy: A reappraisal
22. The use of G-CSF to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer
23. Cisplatin-ifosfamide as neoadjuvant chemotherapy in Stage IIIB cervical uterine squamous-cell carcinoma
24. The prognostic significance of the half-life of serum CA-125 in patients responding to chemotherapy for epithelial ovarian carcinoma